New Research Power Ups Psilocybin’s Potential as an Antidepressant
Depression affects an estimated 300 million people around the world and is the leading cause of disability. Therapeutics for depression...
Home » Biotech Advances » Page 11
Depression affects an estimated 300 million people around the world and is the leading cause of disability. Therapeutics for depression...
Repsol, a Spanish multi-energy company committed to a sustainable world, has entered the biomethane market with an agreement to take...
A novel approach to automating cell therapy manufacturing using industry-standard equipment can potentially reduce human errors, deliver higher quality product,...
The search for a universal flu vaccine has been long and fraught with false starts and dead ends. For more...
For the first time the developmental stages of the deadliest human malaria parasite, Plasmodium falciparum, have been mapped in high...
REGISTER NOW Broadcast Date: Tuesday, May 21, 2024Time: 8:00 am PDT, 11:00 am EDT, 17:00 CEST While humanized animalmodels are...
Novartis has agreed to acquire Mariana Oncology for up to $1.75 billion, the companies said today, in a deal that...
Kevin Marks, PhD, has been involved in successful endeavors to create meaningful medicines over his 20-year career as a cancer...
The brain can direct the immune system to an unexpected degree, capable of detecting, ramping up, and tamping down inflammation,...
James Atwood, PhD, Opentrons Labworks Over the past several years, proteomics has seen a surge in interest among life scientists...
Explore the synergy of chemistry and technology with ChemTech Digest. Dive into the latest research, tech advancements, and scientific discoveries shaping our world.
Copyright 2024 © All Rights Reserved. ChemTech Digest | SiteMap